Mephobarbital Side Effects
Applies to mephobarbital: oral tablet
Nervous system side effects including primarily somnolence (1% to 3%) have been reported. Agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, hallucination, insomnia, anxiety, dizziness, and abnormal thinking have all been reported to occur in less than 1% of treated patients. Headache has been reported with chronic use.[Ref]
Respiratory side effects including hypoventilation and apnea have been reported to occur in less than 1% of treated patients.[Ref]
Hepatic side effects including liver damage have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
Hematologic side effects including megaloblastic anemia have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
1. "Product Information. Mebaral (mephobarbital)" Sanofi Winthrop Pharmaceuticals, New York, NY.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.